What is MRNA stock price today?

MRNA (Moderna Inc) stock is trading at $67.01 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is MRNA stock going up or down today?

MRNA stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MRNA stock now?

The decision to buy MRNA depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MRNA a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MRNA based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MRNA stock overvalued or undervalued?

Use our DCF valuation calculator to determine if MRNA is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is MRNA's P/E ratio?

P/E ratio data for MRNA will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is MRNA's market cap?

MRNA (Moderna Inc) has a market capitalization of $24.52 billion, making it a mid-cap stock.

What is MRNA's price to book ratio?

MRNA trades at a price-to-book (P/B) ratio of 3.31, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does MRNA pay dividends?

MRNA does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is MRNA's dividend yield?

MRNA does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is MRNA stock a good long-term investment?

MRNA's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MRNA's revenue growth rate?

Revenue growth data for MRNA is available on our dashboard with detailed financial statement analysis.

Profitability metrics for MRNA are available on our dashboard with complete income statement analysis.

What are the risks of investing in MRNA?

Key risks for MRNA include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MRNA compare to its competitors?

Compare MRNA to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MRNA's performance and positioning.

What is MRNA's stock price target for 2026?

Our AI model provides price targets for MRNA based on fundamental analysis: Bull case $87.11 (+30%), Base case $77.06 (+15%), Bear case $60.31 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about MRNA?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MRNA. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MRNA's next earnings report?

MRNA reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MRNA - Moderna Inc

NYSE * Healthcare * Biotechnology

$67.01

$-1.26 (-1.85%)

About Moderna Inc

Moderna Inc (MRNA) common stock

Price Chart

Loading chart...

MRNA Key Statistics

Market Cap

$24.52B

P/B Ratio

3.31

How MRNA Compares to Peers

MRNA is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 5

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
MRNA(This stock)	$24.52B	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN
BIIBBiogen Inc	$29.33B	21.4	0%	0.0%	vs BIIB

Data Updated: July 14, 2026 at 8:15 AM EDT

Ready to invest in MRNA?

Commission-free trading available. Affiliate links.

MRNA Lician Score

9% confidence

6.0/10

Good

MRNA has a Lician Score of 6/10 (Good). Strengths: Quality.

value

5.0

growth

5.0

quality

8.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates MRNAacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

MRNA Financial Snowflake

5-axis analysis across key investment dimensions

5.6/10

Neutral

5.0

Value

Valuation vs. sector peers

5.0

Growth

Revenue & earnings trajectory

8.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for MRNA

Dashboard

Enter a ticker to analyze